CYP26A1 Antikörper (C-Term)

Produktnummer ABIN307114

Produktdetails anti-CYP26A1 Antikörper

Target: CYP26A1 (Cytochrome P450, Family 26, Subfamily A, Polypeptide 1 (CYP26A1))

Bindungsspezifität: C-Term

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser CYP26A1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Kreuzreaktivität: Human

Produktmerkmale: CYP450 26 (EC 1.14.-.-), Retinoic acid-metabolizing cytochrome, P450 retinoic acid-inactivating 1, P450RAI, hP450RAI, Retinoic acid 4-hydroxylase,The cytochrome P450 proteins (CYPs) are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. P450 enzymes are classified into subfamilies based on their sequence similarities. CYP26A1, also referred to as retinoic acid-4-hydroxylase, is a major retinoic acid catabolic enzyme. CYP26A1 plays an important role in protecting tailbud tissues from inappropriate exposure to retinoic acid. CYP26A1 transcription is epigenetically regulated by nuclear retinoic acid receptors 2. Mutations in the gene encoding for CYP26A1 are associated with caudal agenesis and spina bifida, imperforate anus, agenesis of the caudal portions of the digestive and urogenital tracts, and malformed lumbosacral skeletal elements. CYP26A1 is upregulated in adenomatous polyposis coli mouse adenomas, human FAP adenomas, human sporadic colon carcinomas, and in the intestine of adenomatous polyposis coli(mcr) mutant zebrafish embryos.

Aufreinigung: Protein A/G Chromatography

Immunogen: Hybridoma produced by the fusion of splenocytes from BALB/c mice immunized with a synthetic peptide derived from the C-terminus of the human CYP450 26A1 protein and mouse myeloma Ag8563 cells.

Klon: F27 P6 A1

Isotyp: IgG2b

Anwendungsinformationen

Applikationshinweise: Antibody can be used for Western blotting (1-2 μg/mL) and immunohistochemistry on formalin-fixed, paraffin-embedded tissues (1-5 μg/mL). Optimal concentration should be evaluated by serial dilutions.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: Provided as solution in phosphate buffered saline with 0.08 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Product should be stored at -20°C. Aliquot to avoid freeze/thaw cycles

Details zu CYP26A1

Target: CYP26A1 (Cytochrome P450, Family 26, Subfamily A, Polypeptide 1 (CYP26A1))

Andere Bezeichnung: Cytochrome p450 26A1 (CYP26A1 Produkte)

Synonyme: CP26 antikoerper, CYP26 antikoerper, P450RAI antikoerper, P450RAI1 antikoerper, Cyp26 antikoerper, P450RA antikoerper, RAH antikoerper, RACE antikoerper, XCYP26A1 antikoerper, cyp26 antikoerper, xCYP26 antikoerper, cp26 antikoerper, p450rai antikoerper, p450rai1 antikoerper, CYP26A antikoerper, cb24 antikoerper, id:ibd5061 antikoerper, wu:fb81e05 antikoerper, cytochrome P450 family 26 subfamily A member 1 antikoerper, cytochrome P450, family 26, subfamily a, polypeptide 1 antikoerper, cytochrome P450 family 26 subfamily A member 1 S homeolog antikoerper, cytochrome P450 family 26 subfamily A member 1 L homeolog antikoerper, cytochrome P450, family 26, subfamily A, polypeptide 1 antikoerper, CYP26A1 antikoerper, Cyp26a1 antikoerper, cyp26a1.S antikoerper, cyp26a1.L antikoerper, cyp26a1 antikoerper

Pathways: Retinoic Acid Receptor Signaling Pathway, Monocarboxylic Acid Catabolic Process